Guidelines for the diagnosis and management of chylomicron retention disease based on a review of the literature and the experience of two centers

Orphanet Journal of Rare Diseases

Volumn 5, Issue 1, 2010, Pages

  Peretti, Noel ^a,b   Sassolas, Agnès ^b,c   Roy, Claude C ^a   Deslandres, Colette ^a   Charcosset, Mathilde ^b,c   Castagnetti, Justine ^b   Pugnet Chardon, Laurence ^b   Moulin, Philippe ^b   Labarge, Sylvie ^b   Bouthillier, Lise ^a   Lachaux, Alain ^b   Levy, Emile ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ LYON 1   (France)

^c HOSPICES CIVILS DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CREATINE KINASE; POLYUNSATURATED FATTY ACID; RETINOL; VITAMIN D; VITAMIN K GROUP; CHYLOMICRON; FATTY ACID; MONOMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; SAR1B PROTEIN, HUMAN;

BONE MATURATION; BONE MINERALIZATION; CARDIOMYOPATHY; CHRONIC DIARRHEA; CLINICAL FEATURE; DIET THERAPY; DRUG MEGADOSE; ENDOSCOPY; ESSENTIAL FATTY ACID DEFICIENCY; FATTY LIVER; GENE; GENE MUTATION; GENOTYPE; HISTOPATHOLOGY; HUMAN; HYPERLIPOPROTEINEMIA TYPE 1; INTESTINE CELL; LOW FAT DIET; MALABSORPTION; PRACTICE GUIDELINE; REVIEW; SAR1B GENE; VITAMIN D DEFICIENCY; ADULT; ALPHA TOCOPHEROL DEFICIENCY; ANTHROPOMETRY; CHILD; COHORT ANALYSIS; DIARRHEA; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; FEMALE; GENETICS; GROWTH DISORDER; INFANT; MALE; MALNUTRITION; METABOLISM; MUTATION; NEUROLOGIC DISEASE; PRESCHOOL CHILD;

ADULT; ANTHROPOMETRY; CHILD; CHILD, PRESCHOOL; CHYLOMICRONS; COHORT STUDIES; DIARRHEA; FATTY ACIDS; FEMALE; GROWTH DISORDERS; HUMANS; INFANT; LIPID METABOLISM DISORDERS; MALABSORPTION SYNDROMES; MALE; MALNUTRITION; MONOMERIC GTP-BINDING PROTEINS; MUTATION; NERVOUS SYSTEM DISEASES; VITAMIN E DEFICIENCY;

EID: 77957171872     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-5-24     Document Type: Review

References (54)

1. The biogenesis of chylomicrons. CM Mansbach SA Siddiqi, Annu Rev Physiol 2010 72 315 333 10.1146/annurev-physiol-021909-135801 20148678
2. The mechanism of the formation and secretion of chylomicrons. T Kindel DM Lee P Tso, Atheroscler Suppl 2010 11 11 16 10.1016/j.atherosclerosissup.2010. 03.003 20493784
3. Microsomal triglyceride transfer protein, the abetalipoproteinemia gene product, mediates the secretion of apolipoprotein B-containing lipoproteins from heterologous cells. JM Leiper JD Bayliss RJ Pease DJ Brett J Scott CC Shoulders, J Biol Chem 1994 269 21951 21954 8071315
4. Familial hypobetalipoproteinemia due to apolipoprotein B R463W mutation causes intestinal fat accumulation and low postprandial lipemia. D Noto AB Cefalu A Cannizzaro M Mina F Fayer V Valenti CM Barbagallo A Tuttolomondo A Pinto C Sciume G Licata M Averna, Atherosclerosis 2009 206 193 198 10.1016/j.atherosclerosis.2009.01.037 19344897
5. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. JR Wetterau LP Aggerbeck ME Bouma C Eisenberg A Munck M Hermier J Schmitz G Gay DJ Rader RE Gregg, Science 1992 258 999 1001 10.1126/science.1439810 1439810
6. Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia. D Sharp L Blinderman KA Combs B Kienzle B Ricci K Wager-Smith CM Gil CW Turck ME Bouma DJ Rader, Nature 1993 365 65 69 10.1038/365065a0 8361539
7. The intracellular transport of chylomicrons requires the small GTPase, Sar1b. CC Shoulders DJ Stephens B Jones, Curr Opin Lipidol 2004 15 191 197 10.1097/00041433-200404000-00012 15017362
8. Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders. B Jones EL Jones SA Bonney HN Patel AR Mensenkamp S Eichenbaum-Voline M Rudling U Myrdal G Annesi S Naik N Meadows A Quattrone SA Islam RP Naoumova B Angelin R Infante E Levy CC Roy PS Freemont J Scott CC Shoulders, Nat Genet 2003 34 29 31 10.1038/ng1145 12692552
9. COPII: a membrane coat formed by Sec proteins that drive vesicle budding from the endoplasmic reticulum. C Barlowe L Orci T Yeung M Hosobuchi S Hamamoto N Salama MF Rexach M Ravazzola M Amherdt R Schekman, Cell 1994 77 895 907 10.1016/0092-8674(94)90138-4 8004676
10. COPII-coated vesicle formation reconstituted with purified coat proteins and chemically defined liposomes. K Matsuoka L Orci M Amherdt SY Bednarek S Hamamoto R Schekman T Yeung, Cell 1998 93 263 275 10.1016/S0092-8674(00)81577-9 9568718
11. Anderson or chylomicron retention disease: Molecular impact of five mutations in the SAR1B gene on the structure and the functionality of Sar1b protein. M Charcosset A Sassolas N Peretti CC Roy C Deslandres D Sinnett E Levy A Lachaux, Mol Genet Metab 2008 93 74 84 10.1016/j.ymgme.2007.08.120 17945526
12. Three ways to make a vesicle. T Kirchhausen, Nat Rev Mol Cell Biol 2000 1 187 198 10.1038/35043117 11252894
13. COPII proteins are required for Golgi fusion but not for endoplasmic reticulum budding of the pre-chylomicron transport vesicle. SA Siddiqi FS Gorelick JT Mahan CM Mansbach, J Cell Sci 2003 116 415 427 10.1242/jcs.00215 12482926
14. Vesicle-associated membrane protein 7 is expressed in intestinal ER. SA Siddiqi J Mahan S Siddiqi FS Gorelick CM Mansbach, J Cell Sci 2006 119 943 950 10.1242/jcs.02803 16495485
15. Anderson's disease (chylomicron retention disease): a new mutation in the SARA2 gene associated with muscular and cardiac abnormalities. M Silvain D Bligny T Aparicio P Laforet A Grodet N Peretti D Menard F Djouadi C Jardel JM Begue F Walker J Schmitz A Lachaux LP Aggerbeck ME Samson-Bouma, Clin Genet 2008 74 546 552 10.1111/j.1399-0004.2008.01069.x 18786134
16. Novel missense mutations of SAR1B gene in an infant with chylomicron retention disease. S Treepongkaruna N Chongviriyaphan U Suthutvoravut D Charoenpipop L Choubtum D Wattanasirichaigoon, J Pediatr Gastroenterol Nutr 2009 48 370 373 10.1097/MPG.0b013e318183188f 19274794
17. Unusual causes of steatorrhoea in infancy and childhood. CM Anderson RR Townley Freemanm P Johansen, Med J Aust 1961 48 2 617 622 13861205
18. Hypobetalipoproteinemia with accumulation of an apoprotein B-like protein in intestinal cells. Immunoenzymatic and biochemical characterization of seven cases of Anderson's disease. ME Bouma I Beucler LP Aggerbeck R Infante J Schmitz, J Clin Invest 1986 78 398 410 10.1172/JCI112590 2426307
19. Anderson's disease: exclusion of apolipoprotein and intracellular lipid transport genes. AH Dannoura N Berriot-Varoqueaux P Amati V Abadie N Verthier J Schmitz JR Wetterau ME Samson-Bouma LP Aggerbeck, Arterioscler Thromb Vasc Biol 1999 19 2494 2508 10521380
20. Action tremor as a manifestation of chylomicron retention disease. S Gauthier A Sniderman, Ann Neurol 1983 14 591 10.1002/ana.410140517 6651243
21. [Anderson's disease. Clinical and morphologic study of 7 cases]. F Lacaille M Bratos ME Bouma J Jos J Schmitz J Rey, Arch Fr Pediatr 1989 46 491 498 2596948
22. Studies on lipoprotein metabolism in a family with jejunal chylomicron retention. A Nemeth U Myrdal B Veress M Rudling L Berglund B Angelin, Eur J Clin Invest 1995 25 271 280 10.1111/j.1365-2362.1995.tb01559.x 7601203
23. Chylomicron retention disease: exclusion of apolipoprotein B gene defects and detection of mRNA editing in an affected family. S Patel M Pessah I Beucler J Navarro R Infante, Atherosclerosis 1994 108 201 207 10.1016/0021-9150(94) 90115-5 7980720
24. Anderson's disease: genetic exclusion of the apolipoprotein-B gene in two families. M Pessah P Benlian I Beucler N Loux J Schmitz C Junien R Infante, J Clin Invest 1991 87 367 370 10.1172/JCI114996 1985110
25. [Anderson's disease]. C Polonovski J Navarro JL Fontaine GF de JM Saudubray L Cathelineau, Ann Pediatr (Paris) 1970 17 342 354 5421321
26. [Idiopathic disorder of intestinal fat transport (Anderson's disease). A further case]. J Rey J Jos F Rey M Leporrier M Dechaux J Ramon J Frezal, Arch Fr Pediatr 1973 30 564 565 4733664
27. Malabsorption, hypocholesterolemia, and fat-filled enterocytes with increased intestinal apoprotein B. Chylomicron retention disease. CC Roy E Levy PH Green A Sniderman J Letarte JP Buts J Orquin P Brochu AM Weber CL Morin, Gastroenterology 1987 92 390 399 3792776
28. Hypobetalipoproteinaemia - a variant of the Bassen-Kornzweig syndrome. BB Scott JP Miller MS Losowsky, Gut 1979 20 163 168 10.1136/gut.20.2.163 428829
29. Anderson's disease: no linkage to the apo B locus. D Strich R Goldstein A Phillips R Shemer Y Goldberg A Razin S Freier, J Pediatr Gastroenterol Nutr 1993 16 257 264 10.1097/00005176-199304000-00006 8492252
30. Chylomicron retention disease: a long term study of two cohorts. N Peretti CC Roy A Sassolas C Deslandres E Drouin A Rasquin E Seidman P Brochu MC Vohl S Labarge R Bouvier ME Samson-Bouma M Charcosset A Lachaux E Levy, Mol Genet Metab 2009 97 136 142 10.1016/j.ymgme.2009.02.003 19285442
31. Cryptogenic cirrhosis in a patient with familial hypocholesterolemia due to a new truncated form of apolipoprotein B. D Bonnefont-Rousselot B Condat A Sassolas S Chebel R Bittar MC Federspiel D Cazals-Hatem E Bruckert, Eur J Gastroenterol Hepatol 2009 21 104 108 10.1097/MEG.0b013e3282ffd9f8 19060634
32. Persistence of the intestinal defect in abetalipoproteinaemia after liver transplantation. CP Braegger DC Belli G Mentha B Steinmann, Eur J Pediatr 1998 157 576 578 10.1007/s004310050882 9686820
33. Liver ultrastructure in abetalipoproteinemia: Evolution of micronodular cirrhosis. JS Partin JC Partin WK Schubert AJ McAdams, Gastroenterology 1974 67 107 118 4135110
34. The neurologic syndrome of vitamin E deficiency: a significant cause of ataxia. HJ Kayden, Neurology 1993 43 2167 2169 8232922
35. Vitamin E and neurologic deficits. RJ Sokol, Adv Pediatr 1990 37 119 148 2176058
36. VLDL exits from the endoplasmic reticulum in a specialized vesicle, the VLDL transport vesicle, in rat primary hepatocytes. SA Siddiqi, Biochem J 2008 413 333 342 10.1042/BJ20071469 18397176
37. Apo B100-containing lipoproteins are secreted by the heart. J Boren MM Veniant SG Young, J Clin Invest 1998 101 1197 1202 10.1172/JCI1785 9502759
38. Genes for apolipoprotein B and microsomal triglyceride transfer protein are expressed in the heart: evidence that the heart has the capacity to synthesize and secrete lipoproteins. LB Nielsen M Veniant J Boren M Raabe JS Wong C Tam L Flynn T Vanni-Reyes MD Gunn IJ Goldberg RL Hamilton SG Young, Circulation 1998 98 13 16 9665054
39. Plasma cholesterol and triglyceride distributions in 13,665 children and adolescents: the Prevalence Study of the Lipid Research Clinics Program. B Christensen C Glueck P Kwiterovich I Degroot G Chase G Heiss R Mowery I Tamir B Rifkind, Pediatr Res 1980 14 194 202 6966785 (Pubitemid 10133512)
40. The role of the microsomal triglygeride transfer protein in abetalipoproteinemia. N Berriot-Varoqueaux LP Aggerbeck M Samson-Bouma JR Wetterau, Annu Rev Nutr 2000 20 663 697 10.1146/annurev.nutr.20.1.663 10940349
41. Variable phenotypic expression of chylomicron retention disease in a kindred carrying a mutation of the Sara2 gene. AB Cefalu PL Calvo D Noto M Baldi V Valenti P Lerro F Tramuto A Lezo I Morra G Cenacchi C Barbera MR Averna, Metabolism 2010 59 463 467 10.1016/j.metabol.2009.07.042 19846172
42. Analysis of dual energy X-ray absorptiometry whole body results in children, adolescents and young adults. PM Braillon P Cochat, Appl Radiat Isot 1998 49 623 624 10.1016/S0969-8043(97)00195-4 9606087
43. Pediatric dual-energy X-ray absorptiometry: technique, interpretation, and clinical applications. LA Binkovitz MJ Henwood P Sparke, Semin Nucl Med 2007 37 303 313 10.1053/j.semnuclmed.2007.02.007 17544629
44. Ataxia with isolated vitamin E deficiency: a clinical, biochemical and genetic diagnosis. G Alex MR Oliver KJ Collins, J Paediatr Child Health 2000 36 515 516 10.1046/j.1440-1754.2000.00534.x 11036814
45. Abetalipoproteinemia treated with parenteral and oral vitamins A and E, and with medium chain triglycerides. E Azizi JL Zaidman J Eshchar A Szeinberg, Acta Paediatr Scand 1978 67 796 801 10.1111/j.1651-2227.1978.tb16264.x 716878
46. Normotriglyceridemic abetalipoproteinemia. absence of the B-100 apolipoprotein. MJ Malloy JP Kane DA Hardman RL Hamilton KB Dalal, J Clin Invest 1981 67 1441 1450 10.1172/JCI110173 7229035
47. The neuropathy of abetalipoproteinemia. RG Miller CJ Davis DR Illingworth W Bradley, Neurology 1980 30 1286 1291 6153056
48. A-beta-lipoproteinemia: clinical and laboratory features, therapeutic manipulations, and follow-up study of three members of a Greek family. JK Triantafillidis G Kottaras S Sgourous P Cheracakis G Driva E Konstantellou A Parasi H Choremi E Samouilidou, J Clin Gastroenterol 1998 26 207 211 10.1097/00004836-199804000-00012 9600371
49. A double-blind trial of vitamin E in angina pectoris. TW Anderson DB Reid, Am J Clin Nutr 1974 27 1174 1178 4214473
50. Alpha tocopherol in CSF of subjects taking high-dose vitamin E in the DATATOP study. Parkinson Study Group. GT Vatassery S Fahn MA Kuskowski, Neurology 1998 50 1900 1902 9633757
51. Bioavailability of a novel, water-soluble vitamin E formulation in malabsorbing patients. K Papas J Kalbfleisch R Mohon, Dig Dis Sci 2007 52 347 352 10.1007/s10620-006-9489-2 17216337
52. Bioavailability of oral vitamin E formulations in adult volunteers and children with chronic cholestasis or cystic fibrosis. E Jacquemin B Hermeziu Y Kibleur I Friteau D Mathieu CF Le D Moyse M Gerardin E Jacqz-Aigrain A Munck, J Clin Pharm Ther 2009 34 515 522 10.1111/j.1365-2710.2009.01027.x 19744007
53. The role of vitamin E in the treatment of the neurological features of abetalipoproteinaemia and other disorders of fat absorption. DP Muller JK Lloyd OH Wolff, J Inherit Metab Dis 1985 8 Suppl 1 88 92 10.1007/BF01800666 3930848
54. Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans. HJ Kayden MG Traber, J Lipid Res 1993 34 343 358 8468520